Currently predicting for Thu, 4 Jun 2026

GERN Prediction Chart

GERN Predictions History

Latest community submissions for GERN.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Sep 22, 2020 $1.85 +2.78% $1.80 X 97.22% 1
Steve Talamantes Steve Talamantes @SteveTalamantes.172449
Sep 22, 2020 $1.60 -11.11% $1.80 X 88.89% 1
iHustle84 iHustle84 Pro
Sep 22, 2020 $1.78 -1.11% $1.80 X 98.89% 2
Todd Wardzinski Todd Wardzinski @ToddWardzinski.172863
Sep 22, 2020 $1.88 +4.17% $1.80 X 95.83% 1
JS JS Pro
Aug 3, 2020 $1.56 -11.86% $1.77 X 88.14% 0
sander7100 yo bro sander7100 yo bro Pro @sander7100yobro.167552
Aug 3, 2020 $1.29 -27.12% $1.77 X 72.88% 0
Aug 3, 2020 $1.65 -6.78% $1.77 X 93.22% 0
JS JS Pro
Jun 19, 2020 $2.09 +8.29% $1.93 X 91.71% 0
Jun 19, 2020 $2.25 +16.58% $1.93 X 83.42% 1
Oct 28, 2019 $1.52 +0.00% $1.52 X 100.00% 10
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for GERN with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT GERON CORPORATION
Geron
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes a...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE